Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML. (Q46287871)
Jump to navigation
Jump to search
scientific article published on 20 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML. |
scientific article published on 20 March 2013 |
Statements
1 reference
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML. (English)
1 reference
1 reference
Nancy E Briggs
1 reference
Susan Branford
1 reference
David T Yeung
1 reference
Jodi A Prime
1 reference
Chani R Field
1 reference
Haley K Altamura
1 reference
Alexandra L Yeoman
1 reference
Jasmina Georgievski
1 reference
Bronte A Jamison
1 reference
Stuart Phillis
1 reference
Brad Sullivan
1 reference
Mark Hertzberg
1 reference
John F Seymour
1 reference
John Reynolds
1 reference
Timothy P Hughes
1 reference
20 March 2013
1 reference
1 reference
121
1 reference
3818-3824
1 reference
19
1 reference
Identifiers
1 reference
1 reference